Avzivi

Avzivi (Bevacizumab) is an intravenous medication used to treat certain types of cancer. This biologic therapy targets specific proteins to help slow tumor growth and spread.

Avzivi is primarily used in the treatment of various cancers, including colorectal, lung, kidney, and cervical cancers. It works by inhibiting the growth of new blood vessels that supply tumors with nutrients, thereby slowing cancer progression. Patients often wonder, 'What is Avzivi used for?' It is typically administered intravenously under medical supervision.

Common effects of Avzivi may include fatigue, high blood pressure, and changes in appetite. Some patients may experience more severe side effects, such as bleeding or blood clots. It is important to discuss any unusual symptoms with a healthcare provider.

Avzivi should be handled with care and administered by trained healthcare professionals. Patients should inform their doctors about any existing medical conditions or allergies before starting treatment. Regular monitoring is essential to manage potential side effects effectively.

Avzivi may interact with other medications, including those that affect blood clotting or immune system function. Patients should avoid taking new medications without consulting their healthcare provider. Alcohol and certain supplements may also interact with Avzivi, so it is important to discuss all current treatments with a doctor.